Lupeng Pharmaceutical Ventures into Hong Kong Stock Exchange: Can Antimicrobial Resistance Inhibitors Shape an 18A New Tale?
May 29, 2026 — 17:00 CST
This Data Is Locked!
This area is available only to Subscribers.
Lupeng Pharmaceutical, a Guangzhou-based company, is making its second attempt at a mainboard IPO on the Hong Kong Stock Exchange. The company's key asset, LP-168,... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
